Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INFLIXIMAB vs INFLIXIMAB-DYYB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INFLIXIMAB vs INFLIXIMAB-DYYB: Safety Overview

Metric INFLIXIMAB INFLIXIMAB-DYYB
Total FAERS Reports 140,189 25,585
Deaths Reported 7,516 632
Death Rate 5.4% 2.5%
Hospitalizations 36,324 6,251
Average Patient Age 43.9 yrs 48.5 yrs
% Female Patients 64.4% 54.0%
Manufacturer Organon LLC CELLTRION USA Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription